U.S. Health Secretary Robert F. Kennedy Jr. plans to announce that use of Kenvue’s popular over-the-counter pain medication Tylenol in pregnant women is potentially linked to autism, The Wall Street Journal reported on Friday, citing people familiar with the matter, without including evidence for the claims.

Kennedy, in a report, will also suggest a medicine derived from folate called folinic acid can be used to treat symptoms of autism in some people, the WSJ reported.

Shares of Kenvue fell 14% after the report. Tylenol, whose active ingredient is acetaminophen, is a widely used pain reliever, including by pregnant women.

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy plans to announce a link between tylenol use in pregnancy to autism. REUTERS

The report, expected

See Full Page